Acrivon Therapeutics, Inc. (ACRV) Earnings
|
Expand Research on ACRV
| Next EPS Date | 8/19/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +47.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/19/26  |
Q226 | N/A | -$0.64 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/13/26 |
Q126 | -$0.49 | -$0.62 | +$0.13 | N/A | N/A | N/A |  | | Details | |
| 3/19/26 |
Q425 | -$0.49 | -$1.21 | +$0.72 | N/A | N/A | N/A | | | Details | |
| 11/13/25 |
Q325 | -$0.47 | -$1.16 | +$0.69 | N/A | N/A | N/A | | | Details | |
| 11/10/25 |
Q325 | N/A | -$1.16 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/7/25 |
Q325 | N/A | -$1.16 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/6/25 |
Q325 | N/A | -$1.16 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/13/25 |
Q225 | -$0.55 | -$1.09 | +$0.54 | N/A | N/A | N/A | | | Details |
